World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
92
Citations
39939
World Ranking
991
National Ranking
90

Medicine

D-Index
93
Citations
40121
World Ranking
10739
National Ranking
1023

Overview

Arthur Kaser is affiliated with the University of Cambridge in the United Kingdom. Their research spans several fields within biochemistry, genetics, molecular biology, and medicine, focusing chiefly on molecular biology, immunology, genetics, epidemiology, and surgery.

The scientist has contributed extensively to topics related to inflammatory bowel disease, microscopic colitis, gut microbiota and health, IL-33/ST2/ILC pathways, immune cell function and interaction, eosinophilic esophagitis, and endoplasmic reticulum stress and disease.

Recent notable publications include:

  • "Crohn's disease," 2020, published in Nature Reviews Disease Primers
  • "Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease," 2020, published in Nature Communications
  • "Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis," 2020, published in Proceedings of the National Academy of Sciences
  • "Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD," 2021, published in Gastroenterology
  • "GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation," 2020, published in Cell Reports

Frequently collaborating co-authors include:

  • Philip Rosenstiel
  • Richard S. Blumberg
  • Konrad Aden
  • Silvio Danese
  • Lisa Mayr

Arthur Kaser has published in various scientific venues, with the most publications appearing in Gastroenterology, Journal of Crohn's and Colitis, Nature Communications, Nature Reviews Disease Primers, and bioRxiv (Cold Spring Harbor Laboratory).

The main fields of study covered by Kaser include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of study include:

  • Molecular Biology
  • Immunology
  • Genetics
  • Epidemiology
  • Surgery

Main research topics developed by Kaser are:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Gut microbiota and health
  • IL-33, ST2, and ILC Pathways
  • Immune Cell Function and Interaction
  • Eosinophilic Esophagitis
  • Endoplasmic Reticulum Stress and Disease

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease

    Arthur Kaser;Ann-Hwee Lee;Andre Franke;Jonathan N. Glickman

  • Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

    Alexander R. Moschen;Arthur Kaser;Barbara Enrich;Birgit Mosheimer

  • Gut microbiome, obesity, and metabolic dysfunction.

    Herbert Tilg;Arthur Kaser

  • Crohn's disease

    Giulia Roda;Siew Chien Ng;Paulo Gustavo Kotze;Marjorie Argollo

  • The unfolded protein response in immunity and inflammation

    Joep Grootjans;Arthur Kaser;Randal J. Kaufman;Richard S. Blumberg

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Paneth cells as a site of origin for intestinal inflammation

    Timon E. Adolph;Michal F. Tomczak;Lukas Niederreiter;Hyun Jeong Ko;Hyun Jeong Ko

  • Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

    Arthur Kaser;Gerald Brandacher;Wolfgang Steurer;Susanne Kaser;Susanne Kaser

  • Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

    S Kaser;A Kaser;A Sandhofer;C.F Ebenbichler

  • Adiponectin and its receptors in non-alcoholic steatohepatitis

    S Kaser;A Moschen;A Cayon;A Kaser

  • Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

    Brian G Feagan;William J Sandborn;Geert D'Haens;Julián Panés

  • Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

    Peter Fickert;Andrea Fuchsbichler;Martin Wagner;Gernot Zollner

  • Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

    M Zaeem Cader;Arthur Kaser

  • Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

    Tom H. Karlsen;Andre Franke;Espen Melum;Arthur Kaser

  • Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation

    Fotios Sampaziotis;Fotios Sampaziotis;Miguel Cardoso de Brito;Pedro Madrigal;Pedro Madrigal;Alessandro Bertero

  • Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations.

    Alexander R. Moschen;Romana R. Gerner;Jun Wang;Jun Wang;Victoria Klepsch

  • Gut, inflammation and osteoporosis: basic and clinical concepts

    H Tilg;A R Moschen;A Kaser;A Pines

  • Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

    Herbert Tilg;Rajiv Jalan;Arthur Kaser;Nathan A Davies

  • Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.

    Gottfried Novacek;Ansgar Weltermann;Anna Sobala;Herbert Tilg

Frequent Co-Authors

Herbert Tilg
Herbert Tilg Innsbruck Medical University
Richard S. Blumberg
Richard S. Blumberg Brigham and Women's Hospital
Stefan Schreiber
Stefan Schreiber Kiel University
Philip Rosenstiel
Philip Rosenstiel Kiel University
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Tom H. Karlsen
Tom H. Karlsen Oslo University Hospital
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Remo Panaccione
Remo Panaccione University of Calgary
Walter Reinisch
Walter Reinisch Medical University of Vienna
Günter Weiss
Günter Weiss Innsbruck Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, pursuing related online degrees can open many doors. Healthcare professionals, especially nurses, often explore accelerated pathways to gain specialized knowledge. For example, transitioning from a Family Nurse Practitioner to a more specialized role can be achieved by obtaining a fnp to acute care certification, which focuses on acute patient management skills that complement immunology work.

Online accelerated nurse practitioner programs are an excellent option for those seeking a faster route to NP roles. The accelerated np programs online provide flexible schedules and intensive coursework designed to prepare students for advanced practice in various specialties, including immunology-related fields.

For career changers with no prior nursing background, the 12-month accelerated nursing programs online for non nurses offer an intensive introduction to nursing fundamentals. This pathway can lead to immunology-focused nursing roles, combining foundational skills with specialized knowledge.

Additionally, those looking for accessible entry points into nursing may consider the easiest absn programs to get into, which can serve as a stepping stone toward advanced degrees in immunology and related healthcare disciplines.

Best Scientists Citing Arthur Kaser

Trending Scientists